IT1398168B1 - Uso di ingredienti attivi in combinazione per il trattamento delle complicanze del diabete. - Google Patents
Uso di ingredienti attivi in combinazione per il trattamento delle complicanze del diabete.Info
- Publication number
- IT1398168B1 IT1398168B1 ITMI2010A000236A ITMI20100236A IT1398168B1 IT 1398168 B1 IT1398168 B1 IT 1398168B1 IT MI2010A000236 A ITMI2010A000236 A IT MI2010A000236A IT MI20100236 A ITMI20100236 A IT MI20100236A IT 1398168 B1 IT1398168 B1 IT 1398168B1
- Authority
- IT
- Italy
- Prior art keywords
- complications
- diabetes
- treatment
- combination
- active ingredients
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2010A000236A IT1398168B1 (it) | 2010-02-16 | 2010-02-16 | Uso di ingredienti attivi in combinazione per il trattamento delle complicanze del diabete. |
| ES201130192A ES2387054B2 (es) | 2010-02-16 | 2011-02-14 | Uso de ingredientes activos en combinación para el tratamiento de complicaciones de la diabetes. |
| ITMI2011A000213A IT1404380B1 (it) | 2010-02-16 | 2011-02-14 | Uso di ingredienti attivi in combinazione per il trattamento delle complicanze del diabete |
| FR1151201A FR2956976B1 (fr) | 2010-02-16 | 2011-02-15 | Utilisation d'ingredients actifs en combinaison pour le traitement des complications du diabete |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2010A000236A IT1398168B1 (it) | 2010-02-16 | 2010-02-16 | Uso di ingredienti attivi in combinazione per il trattamento delle complicanze del diabete. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITMI20100236A1 ITMI20100236A1 (it) | 2011-08-17 |
| IT1398168B1 true IT1398168B1 (it) | 2013-02-14 |
Family
ID=42270257
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITMI2010A000236A IT1398168B1 (it) | 2010-02-16 | 2010-02-16 | Uso di ingredienti attivi in combinazione per il trattamento delle complicanze del diabete. |
| ITMI2011A000213A IT1404380B1 (it) | 2010-02-16 | 2011-02-14 | Uso di ingredienti attivi in combinazione per il trattamento delle complicanze del diabete |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITMI2011A000213A IT1404380B1 (it) | 2010-02-16 | 2011-02-14 | Uso di ingredienti attivi in combinazione per il trattamento delle complicanze del diabete |
Country Status (3)
| Country | Link |
|---|---|
| ES (1) | ES2387054B2 (it) |
| FR (1) | FR2956976B1 (it) |
| IT (2) | IT1398168B1 (it) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2733911B1 (fr) * | 1995-05-09 | 1998-05-29 | Takeda Chemical Industries Ltd | Composition pharmaceutique pour maladies renales ou cardio-vasculaires |
| CN1768735A (zh) * | 2000-03-17 | 2006-05-10 | 味之素株式会社 | 糖尿病性合并症和神经障碍用的药剂及其应用 |
| MXPA03005462A (es) * | 2000-12-18 | 2003-09-25 | Novartis Ag | Combinacion terapeutica de amlodipina y benazepril. |
| PE20040468A1 (es) * | 2002-05-17 | 2004-09-14 | Novartis Ag | Combinacion de compuestos organicos |
| CA2597247A1 (en) * | 2005-02-11 | 2006-08-17 | Regeneron Pharmaceuticals, Inc. | Therapeutic combination of a vegf antagonist (vegf trap) and an anti-hypertensive agent |
-
2010
- 2010-02-16 IT ITMI2010A000236A patent/IT1398168B1/it active
-
2011
- 2011-02-14 ES ES201130192A patent/ES2387054B2/es active Active
- 2011-02-14 IT ITMI2011A000213A patent/IT1404380B1/it active
- 2011-02-15 FR FR1151201A patent/FR2956976B1/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2387054A1 (es) | 2012-09-12 |
| FR2956976A1 (fr) | 2011-09-09 |
| ITMI20100236A1 (it) | 2011-08-17 |
| ITMI20110213A1 (it) | 2011-08-17 |
| ES2387054B2 (es) | 2014-02-13 |
| IT1404380B1 (it) | 2013-11-22 |
| FR2956976B1 (fr) | 2012-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20181364T1 (hr) | Aminotriazolopiridin, namijenjen upotrebi u liječenju upale, te njegovi farmacetski pripravci | |
| PL3517539T3 (pl) | Podstawiona dimeryczna pochodna chinazoliny, sposób jej wytwarzania i jej zastosowanie w kompozycjach farmaceutycznych do leczenia cukrzycy typu I i II | |
| CL2014002757A1 (es) | Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, composicion farmaceutica; y uso en el tratamiento del cancer. | |
| PH12015500115A1 (en) | Glucagon analogues | |
| CL2013003372A1 (es) | Compuestos derivados de espiro-[1,3]-oxacinas y espiro-[1,4]-oxacepinas, inhibidores de bace1 y/o bace2; composicion farmaceutica; procedimiento para prepararlos; y su uso en el tratamiento y/o la profilaxis de la enfermedad de alzheimer y diabetes. | |
| CL2013001654A1 (es) | Compuestos derivados de 6-amino-2-fenilamino-1h-bencimidazol-5-carboxamida; composicion farmaceutica; y su uso en el tratamiento y/o prevencion de las enfermedades inflamatorias y/o afecciones asociadas, en particular el dolor. | |
| FR2975004B1 (fr) | Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant | |
| CL2014000849A1 (es) | Compuestos derivados de benzilindazoles sustituido, inhibidores de la quinasa bub1; procedimiento de fabricacion; composicion farmaceutica; combinacion farmaceutica; y su uso en el tratamiento de enfermedades hiperproliferativas. | |
| CL2015001202A1 (es) | Compuestos derivados de oxazolidin-2-ona-pirimidina; composicion y combinacion farmaceutica y uso en el tratamiento del cancer. | |
| CL2012003322A1 (es) | Compuestos derivados de benzamida sustituidas; composicion farmacéutica; y uso en el tratamiento del cancer. | |
| IT1402082B1 (it) | Strumenti per la preparazione di ravioli o pasta ripiena in genere. | |
| CL2014001959A1 (es) | Compuestos derivados de fenil-1h-imidazo[1,2-b]pirazol sustituidos; procedimiento de preparacion; composicion farmaceutica; y el uso en el tratamiento del cancer. | |
| BR112015012443A2 (pt) | composição de limpeza, método de limpeza do corpo humano, uso da composição e método para prover limpeza | |
| CL2014001323A1 (es) | Compuestos derivados de 3-fenil-isoquinolin-1(2h)-ona, inhibidores de parp-1; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer. | |
| BR112012002490A2 (pt) | composição limpadora com baixa irritabilidade, composição concentrada e seu uso | |
| BR112012002492A2 (pt) | composição limpadora com baixa irritabilidade, composição concentrada e seu uso | |
| CL2013001445A1 (es) | Compuestos derivados de difenilamina; composicion farmaceutica y uso en el tratamiento de enfermedades inflamatorias, tales como cancer. | |
| IT1398875B1 (it) | Composizioni contenti l. mucosae per uso medico. | |
| ES1078238Y (es) | Dosificador ocular para colirios, sueros y otros liquidos de uso higienico o medicinal | |
| IT1398168B1 (it) | Uso di ingredienti attivi in combinazione per il trattamento delle complicanze del diabete. | |
| EP2902024A4 (en) | SYNERGISTIC COMPOSITION OF NITAZOXANIDE AND MÉBENDAZOLE, CORRESPONDING METHODS OF PREPARATION AND USE THEREOF IN THE TREATMENT OF HUMAN PARASITOSIS | |
| CO6801760A2 (es) | Uso de las sales de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio en el tratamiento de enfermedad cardiovascular | |
| ITRM20080027A1 (it) | Uso di aciclovir per il trattamento delle condilomatosi. | |
| TH112788B (th) | สารเตรียมของแข็งทางเภสัชศาสตร์ที่มีสารออกฤทธิ์ตลอดทั้งขอบเขต | |
| CL2014001167A1 (es) | Combinacion que comprende memantina y baclofeno; composicion farmaceutica que la comprende; y uso en el tratamiento del sobrepeso y la obesidad. |